Subscribe
Low awareness of RSV in adults and misperceptions about the goal of vaccination aren't new challenges, says Kelly Moore, MD, MPH, Immunize.org president and CEO.
GSK Adult RSV Vaccine: Expert Highlights Path to FDA Approval
GSK Adult RSV Vaxx: Public Health Expert Reviews Topics for ACIP Meeting in June
First RSV Vaccine Brings "Sense of Relief" to Public Health Experts, Says Immunize.org President
Study Finds COVID-19 Neutralizing Antibody Response Differs by Vaccine Type
Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH
June 15, 2026
Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD
June 17-19, 2026
Seth A. Wander, MD, PhD; Kate Baxstrom, MD
Richard Bedlack, MD, PhD
June 23, 2026
1 Session is Available!
Terry Heiman-Patterson, MD
Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA
Selina R. McGee, OD, FAAO
Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; John Hovanesian, MD, FACS
Seth A. Wander, MD, PhD; Yang Liu, MD
Yelda Nouri, MD; Sara Nunnery, MD, MSCI
July 10-11, 2026
Rachel N. Grisham, MD; Ramez N. Eskander, MD; Oladapo Yeku, MD, PhD